Andrew Hughes
Direttore/Membro del Consiglio presso CellCentric Ltd.
Posizioni attive di Andrew Hughes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Manchester Cancer Research Centre | Corporate Officer/Principal | - | - |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 06/04/2022 | - |
Storia della carriera di Andrew Hughes
Precedenti posizioni note di Andrew Hughes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PCI BIOTECH HOLDING ASA | Direttore/Membro del Consiglio | 01/05/2018 | 25/05/2023 |
| Independent Dir/Board Member | 01/05/2018 | 25/05/2023 | |
| The University of Manchester | Corporate Officer/Principal | 01/01/2006 | - |
| AstraZeneca AS | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Norvegia | 3 |
| Regno Unito | 3 |
| Israele | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
| Aziende private | 3 |
|---|---|
| AstraZeneca AS | |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Manchester Cancer Research Centre |
- Borsa valori
- Insiders
- Andrew Hughes
- Esperienza
